Characteristic | n | Proportion of study group (%) |
Gender | ||
Female | 122 | 57.8 |
Male | 88 | 41.7 |
Transgender | 1 | 0.5 |
Age* | 42.9±12.7* | |
Duration of Crohn’s disease (years) | ||
<1 | 7 | 3.3 |
1–4 | 31 | 14.7 |
5–9 | 47 | 22.2 |
10–14 | 34 | 16.1 |
15+ | 92 | 43.6 |
Duration of perianal fistula (years) | ||
<1 | 18 | 8.5 |
1–4 | 67 | 31.8 |
5–9 | 61 | 28.9 |
10–14 | 25 | 11.8 |
15+ | 40 | 18.9 |
Current/previous medication for perianal fistula | ||
No | 182 | 86.3 |
Yes | 29 | 13.7 |
Previous surgery for perianal fistula | ||
No | 61 | 28.9 |
Yes | 150 | 71.1 |
Previous seton | ||
Yes | 131 | 62.1 |
No | 59 | 27.9 |
Unsure | 21 | 10.0 |
Stoma due to perianal fistula | ||
Yes | 31 | 14.7 |
No | 180 | 85.3 |
Self-reported global fistula rating† | ||
Remission (0) | 21/184‡ | 11.4 |
Mild (1–3) | 42/184 | 22.8 |
Moderate (4–6) | 43/184 | 23.3 |
Severe (≥7) | 78/184 | 42.4 |
*Mean±SD reported.
†Rating on 10-point Likert scale.
‡Denominator is 184, that is, number of phase 3 respondents.